RU94024337A - Antimetastatic agent - Google Patents

Antimetastatic agent

Info

Publication number
RU94024337A
RU94024337A RU94024337/14A RU94024337A RU94024337A RU 94024337 A RU94024337 A RU 94024337A RU 94024337/14 A RU94024337/14 A RU 94024337/14A RU 94024337 A RU94024337 A RU 94024337A RU 94024337 A RU94024337 A RU 94024337A
Authority
RU
Russia
Prior art keywords
antimetastatic agent
agent
antimetastatic
substance
specific activity
Prior art date
Application number
RU94024337/14A
Other languages
Russian (ru)
Other versions
RU2088223C1 (en
Inventor
И.В. Белов
Original Assignee
И.В. Белов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by И.В. Белов filed Critical И.В. Белов
Priority to RU9494024337A priority Critical patent/RU2088223C1/en
Priority to PCT/RU1995/000077 priority patent/WO1996000568A1/en
Publication of RU94024337A publication Critical patent/RU94024337A/en
Application granted granted Critical
Publication of RU2088223C1 publication Critical patent/RU2088223C1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: clinical pharmacology, oncology. SUBSTANCE: method involves the use of the known substance perfluorodecaline as antimetastatic agent. Proposed agent can be used for treatment of oncological patients. EFFECT: enhanced specific activity.

Claims (1)

Антиметастатическое средство относится к клинической фармакологии и может быть использовано для лечения онкологических больных. Целью изобретения является повышение специфической активности. Сущность и новизна изобретения заключается в применении известного вещества перфтордекалина по новому назначению в качестве антиметастатического средства.The antimetastatic agent belongs to clinical pharmacology and can be used to treat cancer patients. The aim of the invention is to increase specific activity. The essence and novelty of the invention lies in the use of the known substance perfluorodecalin for a new purpose as an antimetastatic agent.
RU9494024337A 1994-06-29 1994-06-29 Antimetastatic agent RU2088223C1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU9494024337A RU2088223C1 (en) 1994-06-29 1994-06-29 Antimetastatic agent
PCT/RU1995/000077 WO1996000568A1 (en) 1994-06-29 1995-04-26 Anti-metastatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU9494024337A RU2088223C1 (en) 1994-06-29 1994-06-29 Antimetastatic agent

Publications (2)

Publication Number Publication Date
RU94024337A true RU94024337A (en) 1996-05-10
RU2088223C1 RU2088223C1 (en) 1997-08-27

Family

ID=20157843

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9494024337A RU2088223C1 (en) 1994-06-29 1994-06-29 Antimetastatic agent

Country Status (2)

Country Link
RU (1) RU2088223C1 (en)
WO (1) WO1996000568A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2422310B (en) * 2004-12-02 2006-12-27 Kaizen Matsumoto Carcinogen solvents in reducing the carcinogen concentration of cells
WO2015150293A1 (en) * 2014-04-02 2015-10-08 Zhuwu Zeyi Nail care composition
WO2016178099A1 (en) * 2016-01-04 2016-11-10 Mustafa Pehlivan Nano floro tricyclohexane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289499A (en) * 1978-10-13 1981-09-15 Childrens Hospital Medical Center Selecting perfluorocarbon compounds for synthetic blood
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
WO1994007475A1 (en) * 1992-09-30 1994-04-14 Forman B Mervyn Perfusion of perfluorocarbon compound emulsion during percutaneous transluminal angioplasty

Also Published As

Publication number Publication date
RU2088223C1 (en) 1997-08-27
WO1996000568A1 (en) 1996-01-11

Similar Documents

Publication Publication Date Title
ATE251140T1 (en) N-(2OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBONIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY
ATE328599T1 (en) ANTITUMORAL AGENTS
AR052921A1 (en) USE OF RANOLAZINE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION
PT880350E (en) MULTIPLE SCLEROSIS TREATMENT
MY121548A (en) Compounds and methods for the treatment of cancer
HUP0000057A2 (en) Photochemotherapeutic compositions
CY1105818T1 (en) USES OF ET743 IN THE THERAPEUTIC TREATMENT OF CANCER
ATE62414T1 (en) AGENT FOR THE TREATMENT OF HEART DISEASES.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
ATE267583T1 (en) MEDICINAL PREPARATIONS FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
NO994330L (en) Method of treating a tumor
DE69620458D1 (en) BENZOFURANE CARBOXAMIDES AND SULPHONAMIDES
IT1264530B (en) USE OF POLYSACCHARIDES IN ATROPHIC DEGENERATIVE NEUROPATHIES
ATE77230T1 (en) MELATONIN-CONTAINING AGENTS AND THEIR USES.
ATE275143T1 (en) LINKS
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
DE69612056D1 (en) TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT
RU94024337A (en) Antimetastatic agent
ATE75938T1 (en) THERAPEUTIC AGENT CONTAINING ENANTIOMERS OF PROPAFENONE.
HUP0101602A2 (en) Fertility improving composition and application thereof
RU94041246A (en) Method of psoriasis treatment
RU94038232A (en) Agent enhancing brain circulation
PT1150981E (en) THERAPEUTIC NUCLEOSIDAL COMPOSITION
RU99122488A (en) METHOD FOR TREATING CANCER ENDOMETRY
RU94042570A (en) Antihypoxic agent - wheat seedling sap

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130630